Inga V. Anisimova

Inga V. Anisimova

Auto-generated profile, based on publicly available information

Inga V. Anisimova

Research Centre for Medical Genetics

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
VMValentina V. Miroshnikova
Valentina V. Miroshnikova
OROlga V. Romanova
Olga V. Romanova
OIOlga N. Ivanova
Olga N. Ivanova
MFMikhail A. Fedyakov
Mikhail A. Fedyakov
APAlexandra A. Panteleeva
Alexandra A. Panteleeva
OGOleg Glotov
Oleg Glotov
Familial hypercholesterolemia (FH) is caused by mutations in various genes, including the LDLR, APOB and PSCK9 genes; however, the spectrum of these mutations in Russian individuals has not been fully investigated. In the present study, mutation screening was performed on the LDLR gene and other FH‑associated genes in patients with definite or possible FH, using next‑generation sequencing. In total, 59 unrelated patients were recruited and sorted into two separate groups depending on their age: Adult (n=31; median age, 49; age range, 23‑70) and children/adolescent (n=28; median age, 11; age range, 2‑21). FH‑associated variants were identified in 18 adults and 25 children, demonstrating mutation detection rates of 58 and 89% for the adult and children/adolescent groups, respectively. In the adult group, 13 patients had FH‑associated mutations in the LDLR gene, including two novel variants [NM_000527.4: c.433_434dupG p.(Val145Glyfs*35) and c.1186G>C p.(Gly396Arg)], 3 patients had APOB mutations and two had ABCG5/G8 mutations. In the children/adolescent group, 21 patients had FH‑causing mutations in the LDLR gene, including five novel variants [NM_000527.4: c.325T>G p.(Cys109Gly), c.401G>C p.(Cys134Ser), c.616A>C p.(Ser206Arg), c.1684_1691delTGGCCCAA p.(Pro563Hisfs*14) and c.940+1_c.940+4delGTGA], and 2 patients had APOB mutations, as well as ABCG8 and LIPA mutations, being found in different patients. The present study reported seven novel LDLR variants considered to be pathogenic or likely pathogenic. Among them, four missense variants were located in the coding regions, which corresponded to functional protein domains, and two frameshifts were identified that produced truncated proteins. These variants were observed only once in different patients, whereas a splicing variant in intron 6 (c.940+1_c.940+4delGTGA) was detected in four unrelated individuals. Previously reported variants in the LDLR, APOB, ABCG5/8 and LIPA genes were observed in 33 patients. The LDLR p.(Gly592Glu) variant was detected in 6 patients, representing 10% of the FH cases reported in the present study, thus it may be a major variant present in the Russian population. In conclusion, the present study identified seven novel variants of the LDLR gene and broadens the spectrum of mutations in FH‑related genes in the Russian Federation.

4 September 2023 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
IAInga V. Anisimova
Inga V. Anisimova
SASvetlana Artemyeva
Svetlana Artemyeva
EBElena D. Belousova
Elena D. Belousova
NVNato D. Vashakmadze
Nato D. Vashakmadze
DVDmitry Vladimirovich Vlodavets
Dmitry Vladimirovich Vlodavets
ESEkaterina V. Shreder
Ekaterina V. Shreder
Duchenne muscular dystrophy is one of the most common forms of childhood muscular dystrophies. Its incidence is 1 in 3.5–6 thousand newborn boys according to various sources. The disease is caused by the mutation in the DMD gene coding the dystrophin protein, it leads to the dystrophin absence or malfunction. The disease is characterized by proximal muscle weakness and gastrocnemius muscles pseudohypertrophy. In average, patients lose the ability to walk by themselves by the age of 11 and become nonambulatory. The authors have present modern epidemiological data and etiopathogenesis features of Duchenne muscular dystrophy, and have described clinical signs of different disease stages. The algorithm and key points of differential diagnosis are indicated. Special attention was given to the patients’ management: pathogenetic treatment and rehabilitation of pediatric patients.

1 January 2020 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
NSNatalia Semenova
Natalia Semenova
IAI.V. Anisimova
I.V. Anisimova
NDN.A. Demina
N.A. Demina
AOAnna Orlova
Anna Orlova
Olga ShchaginaOlga Shchagina
Olga Shchagina
UHUfa Republican Children'S Clinical Hospital
Ufa Republican Children'S Clinical Hospital

1 January 2023
Verified
Conference Paper
Closed access
IAInga V. Anisimova
Inga V. Anisimova
RGResearch Centre for Medical Genetics
Research Centre for Medical Genetics
Описываются причины возникновения нарушений интеллектуального развития различной этиологии: воздействие факторов окружающей среды, гипоксически-ишемические поражения мозга, влияние генетических факторов – хромосомных патологий, моногенных заболеваний, болезней геномного импринтинга. DOI:

15 December 2023 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TGT.A. Gremyakova
T.A. Gremyakova
IAI.V. Anisimova
I.V. Anisimova
SASvetlana Artemyeva
Svetlana Artemyeva
EBE.N. Baybarina
E.N. Baybarina
ABA.A. Baranov
A.A. Baranov
MRMoscow State Duma Of The Federal Assembly Of Russia
Moscow State Duma Of The Federal Assembly Of Russia
Вам открыли доступ к файлу. Отправлено с помощью Облако Mail.ru.